Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Clinical trial NCT00366145 · COMPLETED

Trial details

NCT number: NCT00366145
Sponsor: Mesoblast, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Graft Versus Host Disease

Start date: 2006-08-17
Primary completion: 2008-12-26
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.